SATB2 downregulation has been reported in sessile serrated pathway‐associated colorectal carcinomas, IBD associated colorectal carcinomas and dysplasias,20, 21, 22 and here we reveal that it also occurs in SSLs and MVHPs (see Figure 2 and Table 2). The gene discussed is SATB2; the disease is colorectal carcinoma.